tiprankstipranks
Advertisement
Advertisement

IOBT Stock Latest News

IO Biotech Files Chapter 7, Ceases Operations, Liquidates
Company AnnouncementsIO Biotech Files Chapter 7, Ceases Operations, Liquidates
21h ago
8K
IOBT
IO Biotech Faces Nasdaq Noncompliance, Potential Delisting Risk
PremiumCompany Announcements
IO Biotech Faces Nasdaq Noncompliance, Potential Delisting Risk
2M ago
8K
IOBT
IO Biotech launches strategic review amid major restructuring
PremiumCompany Announcements
IO Biotech launches strategic review amid major restructuring
2M ago
8K
IOBT
IO Biotech retains Raymond James as advisor, to reduce workforce
PremiumThe Fly
IO Biotech retains Raymond James as advisor, to reduce workforce
2M ago
IOBT
Midday Fly By: Minnesota CEOs call for deescalation, Nvidia invests in CoreWeave
PremiumThe Fly
Midday Fly By: Minnesota CEOs call for deescalation, Nvidia invests in CoreWeave
2M ago
LE
AMP
Piper downgrades IO Biotech amid strategic alternatives evaluation
PremiumThe FlyPiper downgrades IO Biotech amid strategic alternatives evaluation
2M ago
IOBT
IO Biotech downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
IO Biotech downgraded to Neutral from Overweight at Piper Sandler
2M ago
IOBT
IO Biotech Explores Strategic Alternatives Amid Cost-Cutting Plans
Premium
Company Announcements
IO Biotech Explores Strategic Alternatives Amid Cost-Cutting Plans
2M ago
8K
IOBT
IO Biotech announces exploration of strategic alternatives
PremiumThe Fly
IO Biotech announces exploration of strategic alternatives
2M ago
IOBT
IO Biotech downgraded to Underweight from Equal Weight at Morgan Stanley
PremiumThe Fly
IO Biotech downgraded to Underweight from Equal Weight at Morgan Stanley
3M ago
IOBT
IO Biotech Receives Nasdaq Notice for Bid Price Noncompliance
PremiumCompany Announcements
IO Biotech Receives Nasdaq Notice for Bid Price Noncompliance
3M ago
8K
IOBT
IO Biotech publishes MM1636 trial results in Nature Communications
PremiumThe Fly
IO Biotech publishes MM1636 trial results in Nature Communications
4M ago
IOBT
IO Biotech Announces Resignation of Chief Accounting Officer
PremiumCompany AnnouncementsIO Biotech Announces Resignation of Chief Accounting Officer
4M ago
8K
IOBT
IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials
Premium
Company Announcements
IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials
4M ago
IOBT
IO Biotech Presents at Jefferies Global Healthcare Conference
Premium
Company Announcements
IO Biotech Presents at Jefferies Global Healthcare Conference
4M ago
8K
IOBT
IO Biotech’s Hold Rating Amid Financial and Regulatory Uncertainty
PremiumRatings
IO Biotech’s Hold Rating Amid Financial and Regulatory Uncertainty
5M ago
IOBT
IO Biotech reports Q3 EPS (13c) vs (36c) last year
PremiumThe Fly
IO Biotech reports Q3 EPS (13c) vs (36c) last year
5M ago
IOBT
IO Biotech presents pre-clinical data on IO112, IO170
PremiumThe Fly
IO Biotech presents pre-clinical data on IO112, IO170
5M ago
IOBT
IO Biotech price target lowered to $3 from $10 at Piper Sandler
PremiumThe Fly
IO Biotech price target lowered to $3 from $10 at Piper Sandler
5M ago
IOBT
IO Biotech reports expanded Cylembio results
PremiumThe FlyIO Biotech reports expanded Cylembio results
5M ago
MRK
IOBT
IO Biotech downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
IO Biotech downgraded to Equal Weight from Overweight at Morgan Stanley
6M ago
IOBT
Hold Rating for IO Biotech Amid Regulatory and Financial Challenges
Premium
Ratings
Hold Rating for IO Biotech Amid Regulatory and Financial Challenges
6M ago
IOBT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >